|
|
||||||||
Clinical Chemistry, Vol 39, 97-103, Copyright © 1993 by American Association for Clinical Chemistry
JW Lenders, G Eisenhofer, I Armando, HR Keiser, DS Goldstein and IJ Kopin
Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Metanephrines are O-methylated metabolites of catecholamines. We report the use of liquid chromatography with electrochemical detection to determine plasma concentrations of normetanephrine (NMN) and metanephrine (MN). Plasma NMN and MN in 32 normal volunteers and inpatients were compared with concentrations in 23 patients with pheochromocytoma. Metanephrines were adsorbed from plasma onto a cation- exchange column and eluted with ammoniacal methanol. The dried residue was dissolved in mobile phase and injected onto a reversed-phase column. Recoveries of NMN and MN from 1 mL of plasma averaged 50-70%, and results varied linearly with quantity injected over a range of 0.13- 55 pmol. The detection limit was 25 fmol for NMN and 50 fmol for MN. Intra-assay CVs were < 5%. In normal volunteers and inpatients, plasma concentrations of NMN ranged between 0.12 and 0.73 nmol/L (mean 0.38 nmol/L), and MN between 0.06 and 0.63 nmol/L (mean 0.19 nmol/L). Plasma NMN concentrations were increased in all 23 patients with pheochromocytoma (range 1-172 nmol/L), whereas MN concentrations (range 0.10-382 nmol/L) were increased in only 9 patients. The assay method is reliable and sensitive and offers an approach to examine the extraneuronal metabolism of catecholamines. The method may also be useful in the diagnosis of pheochromocytoma.
The following articles in journals at HighWire Press have cited this article:
![]() |
T. Zelinka, H. J L M Timmers, A. Kozupa, C. C Chen, J. A Carrasquillo, J. C Reynolds, A. Ling, G. Eisenhofer, I. Lazurova, K. T Adams, et al. Role of positron emission tomography and bone scintigraphy in the evaluation of bone involvement in metastatic pheochromocytoma and paraganglioma: specific implications for succinate dehydrogenase enzyme subunit B gene mutations Endocr. Relat. Cancer, March 1, 2008; 15(1): 311 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karagiannis, D. P Mikhailidis, V. G Athyros, and F. Harsoulis Pheochromocytoma: an update on genetics and management Endocr. Relat. Cancer, December 1, 2007; 14(4): 935 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. H.A. de Jong, K. S. Graham, J. C. van der Molen, T. P. Links, M. R. Morris, H. A. Ross, E. G.E. de Vries, and I. P. Kema Plasma Free Metanephrine Measurement Using Automated Online Solid-Phase Extraction HPLC Tandem Mass Spectrometry Clin. Chem., September 1, 2007; 53(9): 1684 - 1693. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Wyller, K. Godang, L. Morkrid, J. P. Saul, E. Thaulow, and L. Walloe Abnormal Thermoregulatory Responses in Adolescents With Chronic Fatigue Syndrome: Relation to Clinical Symptoms Pediatrics, July 1, 2007; 120(1): e129 - e137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Landa, S. I. Garcia, M. L. Schuman, A. Burgueno, A. L. Alvarez, F. E. Saravia, C. Gemma, and C. J. Pirola Knocking down the diencephalic thyrotropin-releasing hormone precursor gene normalizes obesity-induced hypertension in the rat Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1388 - E1394. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. L. M. Timmers, A. Kozupa, G. Eisenhofer, M. Raygada, K. T. Adams, D. Solis, J. W. M. Lenders, and K. Pacak Clinical Presentations, Biochemical Phenotypes, and Genotype-Phenotype Correlations in Patients with Succinate Dehydrogenase Subunit B-Associated Pheochromocytomas and Paragangliomas J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 779 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Brouwers, G. Eisenhofer, J. J. Tao, J. A. Kant, K. T. Adams, W. M. Linehan, and K. Pacak High Frequency of SDHB Germline Mutations in Patients with Malignant Catecholamine-Producing Paragangliomas: Implications for Genetic Testing J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4505 - 4509. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-T. Huynh, K. Pacak, F. M Brouwers, M. S Abu-Asab, R. A Worrell, M. M Walther, A. G Elkahloun, D. S Goldstein, S. Cleary, and G. Eisenhofer Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 Eur. J. Endocrinol., October 1, 2005; 153(4): 551 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, D. S. Goldstein, P. Sullivan, G. Csako, F. M. Brouwers, E. W. Lai, K. T. Adams, and K. Pacak Biochemical and Clinical Manifestations of Dopamine-Producing Paragangliomas: Utility of Plasma Methoxytyramine J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, J. W.M. Lenders, D. S. Goldstein, M. Mannelli, G. Csako, M. M. Walther, F. M. Brouwers, and K. Pacak Pheochromocytoma Catecholamine Phenotypes and Prediction of Tumor Size and Location by Use of Plasma Free Metanephrines Clin. Chem., April 1, 2005; 51(4): 735 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Heider, B. G. Davis, and E. L. Frank Nonparametric Determination of Reference Intervals for Plasma Metanephrine and Normetanephrine Clin. Chem., December 1, 2004; 50(12): 2381 - 2384. [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, I. J. Kopin, and D. S. Goldstein Catecholamine Metabolism: A Contemporary View with Implications for Physiology and Medicine Pharmacol. Rev., September 1, 2004; 56(3): 331 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sawka, A. Gafni, L. Thabane, and W. F. Young Jr. The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2859 - 2866. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. de Galan, C. J. Tack, J. J. Willemsen, C. G. J. Sweep, P. Smits, and J. W. M. Lenders Plasma Metanephrine Levels Are Decreased in Type 1 Diabetic Patients with a Severely Impaired Epinephrine Response to Hypoglycemia, Indicating Reduced Adrenomedullary Stores of Epinephrine J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2057 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Lagerstedt, D. J. O'Kane, and R. J. Singh Measurement of Plasma Free Metanephrine and Normetanephrine by Liquid Chromatography-Tandem Mass Spectrometry for Diagnosis of Pheochromocytoma Clin. Chem., March 1, 2004; 50(3): 603 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Willemsen, C.G.J. Sweep, J. W.M. Lenders, and H. A. Ross Stability of Plasma Free Metanephrines during Collection and Storage as Assessed by an Optimized HPLC Method with Electrochemical Detection Clin. Chem., November 1, 2003; 49(11): 1951 - 1953. [Full Text] [PDF] |
||||
![]() |
Y. C. Kudva, A. M. Sawka, and W. F. Young Jr. The Laboratory Diagnosis of Adrenal Pheochromocytoma: The Mayo Clinic Experience J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4533 - 4539. [Full Text] [PDF] |
||||
![]() |
E. L. Bravo and R. Tagle Pheochromocytoma: State-of-the-Art and Future Prospects Endocr. Rev., August 1, 2003; 24(4): 539 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, D. S. Goldstein, M. M. Walther, P. Friberg, J. W. M. Lenders, H. R. Keiser, and K. Pacak Biochemical Diagnosis of Pheochromocytoma: How to Distinguish True- from False-Positive Test Results J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2656 - 2666. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Goldstein, C. Holmes, Y. Sharabi, S. Brentzel, and G. Eisenhofer Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension Neurology, April 22, 2003; 60(8): 1327 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Sawka, R. Jaeschke, R. J. Singh, and W. F. Young Jr. A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 553 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weise, G. Eisenhofer, and D. P. Merke Pubertal and Gender-Related Changes in the Sympathoadrenal System in Healthy Children J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5038 - 5043. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, G. Eisenhofer, S. L. Mehlinger, A. Carlson, R. Wesley, M. F. Keil, G. P. Chrousos, M. I. New, and D. P. Merke Adrenomedullary Function May Predict Phenotype and Genotype in Classic 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3031 - 3037. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Weise, D. P. Merke, K. Pacak, M. M. Walther, and G. Eisenhofer Utility of Plasma Free Metanephrines for Detecting Childhood Pheochromocytoma J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1955 - 1960. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, M. Weise, S. R. Bornstein, G. Eisenhofer, M. F. Keil, G. P. Chrousos, and D. P. Merke Children with Classic Congenital Adrenal Hyperplasia Have Elevated Serum Leptin Concentrations and Insulin Resistance: Potential Clinical Implications J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2114 - 2120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. M. Lenders, K. Pacak, M. M. Walther, W. M. Linehan, M. Mannelli, P. Friberg, H. R. Keiser, D. S. Goldstein, and G. Eisenhofer Biochemical Diagnosis of Pheochromocytoma: Which Test Is Best? JAMA, March 20, 2002; 287(11): 1427 - 1434. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Taylor and R. J. Singh Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Analysis of Urinary Conjugated Metanephrine and Normetanephrine for Screening of Pheochromocytoma Clin. Chem., March 1, 2002; 48(3): 533 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pacak, D. S. Goldstein, J. L. Doppman, B. L. Shulkin, R. Udelsman, and G. Eisenhofer A ""Pheo"" Lurks: Novel Approaches for Locating Occult Pheochromocytoma J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3641 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roden, W. Raffesberg, W. Raber, E. Bernroider, B. Niederle, W. Waldhausl, and S. Gasic Quantification of Unconjugated Metanephrines in Human Plasma without Interference by Acetaminophen Clin. Chem., June 1, 2001; 47(6): 1061 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, M. M. Walther, T.-T. Huynh, S.-T. Li, S. R. Bornstein, A. Vortmeyer, M. Mannelli, D. S. Goldstein, W. M. Linehan, J. W. M. Lenders, et al. Pheochromocytomas in von Hippel-Lindau Syndrome and Multiple Endocrine Neoplasia Type 2 Display Distinct Biochemical and Clinical Phenotypes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 1999 - 2008. [Abstract] [Full Text] |
||||
![]() |
F. Rao, H. R. Keiser, and D. T. O'Connor Malignant Pheochromocytoma : Chromaffin Granule Transmitters and Response to Treatment Hypertension, December 1, 2000; 36(6): 1045 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. Merke, G. P. Chrousos, G. Eisenhofer, M. Weise, M. F. Keil, A. D. Rogol, J. J. V. Wyk, and S. R. Bornstein Adrenomedullary Dysplasia and Hypofunction in Patients with Classic 21-Hydroxylase Deficiency N. Engl. J. Med., November 9, 2000; 343(19): 1362 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Raber, W. Raffesberg, M. Bischof, C. Scheuba, B. Niederle, S. Gasic, W. Waldhausl, and M. Roden Diagnostic Efficacy of Unconjugated Plasma Metanephrines for the Detection of Pheochromocytoma Arch Intern Med, October 23, 2000; 160(19): 2957 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, J. W.M. Lenders, W. M. Linehan, M. M. Walther, D. S. Goldstein, and H. R. Keiser Plasma Normetanephrine and Metanephrine for Detecting Pheochromocytoma in von Hippel-Lindau Disease and Multiple Endocrine Neoplasia Type 2 N. Engl. J. Med., June 17, 1999; 340(24): 1872 - 1879. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Kopin, B. Rundqvist, P. Friberg, J. Lenders, D. S. Goldstein, and G. Eisenhofer Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm Am J Physiol Regulatory Integrative Comp Physiol, July 1, 1998; 275(1): R165 - R173. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, H. Keiser, P. Friberg, E. Mezey, T.-T. Huynh, B. Hiremagalur, T. Ellingson, S. Duddempudi, A. Eijsbouts, and J. W. M. Lenders Plasma Metanephrines Are Markers of Pheochromocytoma Produced by Catechol-O-Methyltransferase Within Tumors J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2175 - 2185. [Abstract] [Full Text] |
||||
![]() |
G. Eisenhofer, B. Rundqvist, and P. Friberg Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R626 - R634. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, A. Aneman, P. Friberg, D. Hooper, L. Fandriks, H. Lonroth, B. Hunyady, and E. Mezey Substantial Production of Dopamine in the Human Gastrointestinal Tract J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3864 - 3871. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Eisenhofer, P. Friberg, B. Rundqvist, A. A. Quyyumi, G. Lambert, D. M. Kaye, I. J. Kopin, D. S. Goldstein, and M. D. Esler Cardiac Sympathetic Nerve Function in Congestive Heart Failure Circulation, May 1, 1996; 93(9): 1667 - 1676. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |